We are live on ! Find out more
GL

GLG LLC Portfolio holdings

AUM $1.39B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+24.01%
3 Year Est. Return
+43.2%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
+$71.7M
Cap. Flow
-$26.6M
Cap. Flow %
-1.9%
Top 10 Hldgs %
17.58%
Holding
554
New
75
Increased
71
Reduced
347
Closed
50

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.1M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.7M
3
PFE icon
Pfizer
PFE
+$7.76M
4
CP icon
Canadian Pacific Kansas City
CP
+$7.34M
5
NSC icon
Norfolk Southern
NSC
+$6.51M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$10.5M
2
MU icon
Micron Technology
MU
+$8.09M
3
ALLY icon
Ally Financial
ALLY
+$8M
4
PXD
Pioneer Natural Resource Co.
PXD
+$7.65M
5
PG icon
Procter & Gamble
PG
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 12.53%
2 Financials 11.31%
3 Technology 9.48%
4 Energy 9.24%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
51
IBM
IBM
$200B
$7.36M 0.53%
48,451
+11,010
+29% +$1.67M
PM icon
52
Philip Morris
PM
$300B
$7.2M 0.51%
74,080
-7,194
-9% -$721K
UNH icon
53
UnitedHealth
UNH
$383B
$7.07M 0.5%
50,463
-4,669
-8% -$654K
ORCL icon
54
Oracle
ORCL
$350B
$6.87M 0.49%
174,800
-15,029
-8% -$612K
ALXN
55
DELISTED
Alexion Pharmaceuticals
ALXN
$6.86M 0.49%
56,010
+12,162
+28% +$1.57M
MDT icon
56
Medtronic
MDT
$107B
$6.78M 0.48%
78,460
-16,264
-17% -$1.42M
DD icon
57
DuPont de Nemours
DD
$18.3B
$6.77M 0.48%
51,611
+38,007
+279% +$5.07M
BMY icon
58
Bristol-Myers Squibb
BMY
$123B
$6.76M 0.48%
125,471
-15,554
-11% -$999K
TWX
59
DELISTED
Time Warner Inc
TWX
$6.69M 0.48%
84,079
-6,908
-8% -$540K
JNJ icon
60
Johnson & Johnson
JNJ
$599B
$6.61M 0.47%
55,971
-86,548
-61% -$10.5M
BIIB icon
61
Biogen
BIIB
$29.5B
$6.59M 0.47%
21,038
-19,799
-48% -$5.86M
PG icon
62
Procter & Gamble
PG
$347B
$6.39M 0.46%
71,250
-84,838
-54% -$7.37M
CELG
63
DELISTED
Celgene Corp
CELG
$6.35M 0.45%
60,763
-4,893
-7% -$530K
VVV icon
64
Valvoline
VVV
$5.04B
$6.08M 0.43%
+259,000
New +$6.11M
WMB icon
65
Williams Companies
WMB
$90.7B
$5.96M 0.43%
193,904
+44,863
+30% +$1.19M
GILD icon
66
Gilead Sciences
GILD
$165B
$5.71M 0.41%
72,203
-6,955
-9% -$565K
MO icon
67
Altria Group
MO
$125B
$5.7M 0.41%
90,192
-8,925
-9% -$593K
MA icon
68
Mastercard
MA
$484B
$5.65M 0.4%
55,475
-4,715
-8% -$452K
CVS icon
69
CVS Health
CVS
$137B
$5.4M 0.39%
60,645
-4,865
-7% -$459K
MCD icon
70
McDonald's
MCD
$190B
$5.28M 0.38%
45,799
-25,862
-36% -$3.06M
QCOM icon
71
Qualcomm
QCOM
$180B
$5.26M 0.38%
76,800
+75,084
+4,376% +$4.57M
ALLY icon
72
CALL
Ally Financial
ALLY
$14B
$5.25M 0.37%
269,500
-319,100
-54% -$5.93M
ET icon
73
CALL
Energy Transfer Partners
ET
$69.8B
$5.24M 0.37%
312,000
-925,000
-75% -$15.6M
SWK icon
74
Stanley Black & Decker
SWK
$13.6B
$5.23M 0.37%
42,518
+8,016
+23% +$968K
TSLA icon
75
PUT
Tesla
TSLA
$1.39T
$5.1M 0.36%
+375,000
New +$5.41M
1 2
3
4 5

Similar funds

IH
IFC Holdings Tampa, Florida $1.45B AUM 15.5% 1-Year Est. Return
TAM
TPH Asset Management Houston, Texas $1.01B AUM 2.14% 1-Year Est. Return
SI
SII Investments Appleton, Wisconsin $965M AUM 15.44% 1-Year Est. Return
GES
GO ETF Solutions London, United Kingdom $689M AUM 29.59% 1-Year Est. Return
AS
Acorns Securities Irvine, California $660M AUM
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
BTIS
BB&T Investment Services Charlotte, North Carolina $595M AUM 15.91% 1-Year Est. Return

GLG LLC's Q3 2016 Portfolio in Review

As of Q3 2016, GLG LLC held 554 positions worth $1.4B, up 5.4% from $1.33B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

GLG LLC's Q3 2016 filing shows 75 new, 71 increased, 347 reduced and 50 closed positions. Its largest new stake was Johnson Controls International: 240,230 shares worth $11.2M. The largest sale was Johnson & Johnson, an estimated $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • GLG LLC's largest Q3 2016 buy was Johnson Controls International: 240,230 shares worth $11.2M.
  • GLG LLC added most to Pfizer in Q3 2016, an estimated $7.76M increase.
  • GLG LLC's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $10.5M.
  • GLG LLC fully exited Monsanto Co in Q3 2016, selling an estimated $4.82M.
  • GLG LLC's ten largest holdings make up 18% of its $1.4B portfolio in Q3 2016.
  • GLG LLC opened 75 new positions and closed 50 in Q3 2016.
  • GLG LLC's portfolio value rose 5.4% quarter-over-quarter to $1.4B.

Based on GLG LLC's 13F filing for Q3 2016, filed 14 Nov 2016.